Qian Tong, Chengqiang Yin, Xudong Hang, Yuefan Bai, Chongwen Zhang, Jingcheng Xu, Yan Huang, Yixin Ge, Tianyu Chen, Liping Zeng, Jia Jia, Hongkai Bi
Currently, Helicobacter pylori eradication by antibiotic therapy faces various challenges, including antibiotic resistance, side effects on intestinal commensal bacteria, and patient compliance. In this study, loureirin A (LrA), a traditional Chinese medicine monomer extracted from Sanguis Draconis flavones, was found to possess specific antibacterial activity against H. pylori without the bacteria displaying a tendency to develop resistance in vitro . LrA demonstrated a synergistic or additive effect when combined with omeprazole (a proton pump inhibitor) against H...
April 24, 2024: Antimicrobial Agents and Chemotherapy